Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (231-240 of 270) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2018
Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate CancerAmilcar Flores-Morales, Tobias B Bergmann, Charlotte Lavallee, et al.
Molecular Cancer Therapeutics|September 29, 2018
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder CancerTilman Todenhöfer, Roland Seiler, Craig Stewart, et al.
Journal of the National Cancer Institute|October 17, 2023
Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progressionTianfang Ma, Lianjin Jin, Shanshan Bai, et al.
The Journal of Pathology|February 20, 2015
Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour developmentQian Wang, Rae-Anne Hardie, Andrew J Hoy, et al.
Cancer Research|May 14, 2021
SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate CancerRafael S Martinez, Mark J Salji, Linda Rushworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancerBetul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Nature Communications|March 26, 2026
A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADARYang Yi, Yanqiang Li, Rui Wang, et al.
Cancer Research|December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug developmentDong Lin, Alexander W Wyatt, Hui Xue, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2016
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISHTamara L Lotan, Wei Wei, Olga Ludkovski, et al.
The Prostate|June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy CohortJames D Brooks, Wei Wei, Jonathan R Pollack, et al.
Pageof 27

Showing results (231-240 of 270) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2018
Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate CancerAmilcar Flores-Morales, Tobias B Bergmann, Charlotte Lavallee, et al.
Molecular Cancer Therapeutics|September 29, 2018
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder CancerTilman Todenhöfer, Roland Seiler, Craig Stewart, et al.
Journal of the National Cancer Institute|October 17, 2023
Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progressionTianfang Ma, Lianjin Jin, Shanshan Bai, et al.
The Journal of Pathology|February 20, 2015
Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour developmentQian Wang, Rae-Anne Hardie, Andrew J Hoy, et al.
Cancer Research|May 14, 2021
SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate CancerRafael S Martinez, Mark J Salji, Linda Rushworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancerBetul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Nature Communications|March 26, 2026
A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADARYang Yi, Yanqiang Li, Rui Wang, et al.
Cancer Research|December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug developmentDong Lin, Alexander W Wyatt, Hui Xue, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2016
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISHTamara L Lotan, Wei Wei, Olga Ludkovski, et al.
The Prostate|June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy CohortJames D Brooks, Wei Wei, Jonathan R Pollack, et al.
Pageof 27